Bone Disease and Idiopathic Hypercalciuria

Seminars in Nephrology

Volumn 28, Issue 2, 2008, Pages 133-142

  Zerwekh, Joseph E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

bone histomorphometry; genetics; hypercalciuric stone formers; nutrition; Osteopenia

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; COLLAGEN; DEOXYPYRIDINOLINE; HYDROXYPROLINE; PARATHYROID HORMONE; PROSTAGLANDIN E2; PYRIDINOLINE;

ARTICLE; BONE ATROPHY; BONE DENSITY; BONE DISEASE; BONE MINERAL; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM STONE; CALCIUM URINE LEVEL; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HEREDITY; HUMAN; HYPERPARATHYROIDISM; IDIOPATHIC HYPERCALCIURIA; INTESTINE ABSORPTION; METABOLISM; MORPHOMETRICS; NEPHROLITHIASIS; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN INTAKE; SECONDARY HYPERPARATHYROIDISM;

BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; BONE RESORPTION; DIET; HUMANS; HYPERCALCIURIA; UROLITHIASIS;

EID: 40849102505     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.01.006     Document Type: Article

References (61)

1. Alhava E.M., Juuti M., and Karjalainen P. Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 10 (1976) 154-156
2. Fuss M., Pepersack T., Van Geel J., et al. Involvement of low calcium diet in the reduced mineral content in idiopathic renal stone formers. Calcif Tissue Int 46 (1990) 9-13
3. Casez J.P., Hug C., Ackermann D., et al. Bone mineral density of lumbar spine, femoral neck and distal tibia in patients with calcium nephrolithiasis. [abstract]. Urol Res 18 (1990) 66
4. Casez J.P., Hug C., Hess B., et al. The myth of low bone mass in idiopathic calcium renal stone formers. [abstract]. Kidney Int 44 (1993) 264-1993
5. Barkin J., Wilson D.R., Manuel M.A., et al. Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 11 (1985) 19-24
6. Velentzas C., Oreopoulos D.G., Meema S., et al. Dietary calcium restriction may be good for patient's stone but not for their bones. In: Smith L., Robertson W.G., and Finlayson B. (Eds). Urolithiasis; clinical and basic research (1981), Plenum, New York 847-854
7. Pietschmann F., Breslau N.A., and Pak C.Y.C. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7 (1992) 1383-1388
8. Alonso E., Durrego P., Blassini A., et al. Role of cytokines and type of hypercalciuria in the bone mineral loss of idiopathic hypercalciuria. [abstract] (1993) XIIth International Congress of Nephrology. Jun 13-18, Jerusalem, Israel
9. Jaeger P., Lippuner K., Casez J.P., et al. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9 (1994) 1525-1532
10. Fuss M., Gillet C., Simon J., et al. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 9 (1983) 32-34
11. Bataille P., Bergot C., Fournier A., et al. Lower vertebral density in calcium stone formers with normocalciuria and idiopathic hypercalciuria. Evidence for primary bone resorption in idiopathic hypercalciuria. In: Dirk S.J.M., and Sutham R.H. (Eds). Proceedings of VIth International Symposium on Urolithiasis (1988), Plenum, New York 391-397
12. Pacific R., Rothstein M., Pifas L., et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71 (1990) 138-145
13. Hess B., Casez J.P., Takkinen D., et al. Relative hypoparathyroidism and calcitriol upregulation in hypercalciuric calcium renal stone formers; impact of nutrition. Am J Nephrol 13 (1993) 18-26
14. Lawoyin S., Sismilich S., Browne R., et al. Bone mineral content in patients with calcium urolithiasis. Metabolism 28 (1979) 1250-1254
15. Lindergard B., Colleen S., Mansson W., et al. Calcium loading test and bone disease in patients with urolithiasis. Proc Eur Dial Transplant Assoc 20 (1983) 460-465
16. Malvasi L., Sartori L., Giannimi S., et al. Mineral metabolism and bone mineral content in calcium nephrolithiasis with or without hyperparathyroidism. [abstract]. Urol Res 16 (1988) 190
17. Bataille D., Achard J.M., Fournier A., et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39 (1991) 1193-1205
18. Borghi L., Meschi T., Guerra A., et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 46 (1991) 1334-1338
19. Audran M., Bataille P., Sebert J.L., et al. La densite osseuse dans l'hypercalciurie idiopathique chez l'homme. Rev Rhum Mal Osteoartic 58 (1991) 747-750
20. Heilberg I.P., Martini L.A., Szejnfeld V.L., et al. Bone disease in calcium stone forming patients. Clin Nephrol 42 (1994) 175-182
21. Asplin J.R., Bauer K.A., Kinder J., et al. Bone mineral density and urine calcium concentration among subjects with and without hypercalciuria. Kidney Int 63 (2003) 662-669
22. Asplin J.R., Coe F.L., and Favus M. Nephrolithiasis. In: Brenner B.M. (Ed). The kidney. 6th ed. (2000), W.B. Saunders, Philadelphia 1774-1819
23. Bushinsky D.A., and Lechleider R.J. Mechanism of proton-induced bone calcium release: calcium carbonate dissolution. Am J Physiol 253 (1987) F998-F1005
24. + stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol 253 (1987) E90-E98
25. Melton III L.J., Atkinson E.J., O'Fallon W.M., et al. Long-term fracture prediction by bone mineral density assessed at different skeletal sites. J Bone Miner Res 8 (1993) 1227-1233
26. Cummings S.R., Black D.M., Nevitt L., et al. Bone density at various sites for prediction of hip fractures. Lancet 341 (1993) 72-75
27. Melton III L.J., Crowson C.S., Khosla S., et al. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53 (1998) 459-464
28. Sowers M.R., Jannausch M., Wood C., et al. Prevalence of renal stones in a population-based study of dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147 (1998) 914-920
29. Lauderdale D.S., Thisted R.A., Wen M., et al. Bone mineral density and fracture among prevalent kidney stone cases in the third national health and nutrition examination survey. J Bone Miner Res 16 (2001) 1893-1898
30. Garnero P., and Delmas P.D. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am 27 (1998) 303-323
31. Bordier P., Ryckewart A., Gueris J., et al. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 63 (1977) 398-409
32. De Vernejoul M.C., Hioco D., Villaumey J., et al. Etude histomorpometrique osseuse au cours de l'hypercalciurie idiopathique. Rev Rhum Mal Osteoartic 48 (1981) 389-395
33. Malluche H.H., Tschoepe W., Ritz E., et al. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50 (1980) 654-658
34. Steiniche T., Mosekilde L., Christensen M.S., et al. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand 97 (1989) 309-316
35. Da Silva A.M.M., Dos Reis L.M., Pereira R.C., et al. Bone histomorphometric and bone mineral content in idiopathic hypercalciuria patients. [abstract] (1993) XIIth International Congress of Nephrology. Jun 13-18, Jerusalem, Israel
36. Bataille P., Hardy P., Marie A., et al. Decreased bone formation in idiopathic hypercalciuric calcium stone formers explains reduced bone density. [abstract]. J Bone Miner Res 10 Suppl 1 (1995) 401
37. Heller H.J., Zerwekh J.E., Gottschalk F.A., et al. Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int 71 (2007) 808-815
38. Weisinger J.R., Alonzo E., Machado C., et al. Papel de hueso en la fisiopatologia de la hypercalciuria idiopatica: efecto del aminobisfosfonato alendronato. Medicina 57 Suppl 1 (1997) 45-48
39. Bushinsky D.A., Neumann K.J., Asplin J., et al. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55 (1999) 234-243
40. Sakhaee K., Nicar M.J., Glass K., et al. Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism. J Clin Endocrinol Metab 61 (1985) 368-373
41. Lemann Jr. J., Litzow J.R., and Lennon E.J. The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 45 (1966) 1608-1614
42. Amanzadeh J., Gitomer W., Zerwekh J.E., et al. Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int 64 (2003) 2142-2149
43. 2+ transport proteins. J Am Soc Nephrol 17 (2006) 617-626
44. Reddy S.T., Wang C.Y., Sakhaee K., et al. Effect of low carbohydrate, high protein diet on acid-base balance, stone forming propensity and calcium metabolism. Am J Kidney Dis 40 (2002) 265-274
45. Zerwekh J.E., Zou L., Pak C.Y.C., et al. Biochemical and histological assessment of the effects of alkali therapy on bone during high animal protein intake (2007) Paper presented at: 29th Annual Meeting of the American Society for Bone and Mineral Research; Sept 16; Honolulu, HI
46. Sakhaee K., Maalouf N.M., Abrams S.A., et al. Effects of potassium alkali and calcium supplementation on bone turnover in postmenopausal women. J Clin Endocrinol Metab 90 (2005) 3528-3533
47. Buck A.C., Lote C.J., and Sampson W.F. The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 129 (1983) 421-426
48. Raisz L.G., and Martin T.J. Prostaglandins in bone and mineral metabolism. In: Peck W.A. (Ed). Bone and mineral research, annual 2 (1983), Elsevier Science, Amsterdam 286-310
49. Fall P.M., Breault D.T., and Raisz L.G. Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblastic cell line, Py1a: structure activity relations and signal transduction mechanisms. J Bone Miner Res 9 (1994) 1935-1943
50. Weisinger J.R., Alonzo E., Bellorin-Font E., et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49 (1996) 244-250
51. Ghazali A., Fuentes V., Desaint C., et al. Low bone mineral density and peripheral blood monocytes activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82 (1997) 32-38
52. Baggio B., and Budakovic A. Fatty acids and idiopathic nephrolithiasis. Urol Int 75 (2005) 97-101
53. Reed B.Y., Gitomer W.L., Heller H.J., et al. Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87 (2002) 1476-1485
54. Raisz L.G., Kream B.E., Smith M.D., et al. Comparison of the effects of vitamin D metabolites on collagen synthesis and resorption of fetal rat bone in organ culture. Calcif Tissue Int 32 (1980) 135-138
55. Broadus A.E., Erickson S.B., Gertner J.M., et al. An experimental human model of 1,25-dihydroxyvitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 59 (1984) 202-206
56. Broadus A.E., Insogna K.L., Lang R., et al. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311 (1984) 73-80
57. Breslau N.A., Preminger G.M., Adams B.V., et al. Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75 (1992) 1446-1452
58. Favus M.J., Karnauskas A.J., Parks J.H., et al. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89 (2004) 4937-4943
59. 3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24 (1998) 307-313
60. Karnauskas A.J., van Leeuwen J.P., van den Bemd G.J., et al. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20 (2005) 447-454
61. 3 in bone from genetic hypercalciuric rats. Am J Physiol 271 (1996) C130-C135